yiqibuvir
Small moleculeexperimental
Clinical trial activity
6 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Mar 6, 2019 (NCT03903081)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05998304 | Phase 1 | Aug 10, 2023 | Sunshine Lake Pharma Co., Ltd. |
| NCT05504876 | Phase 1 | Nov 7, 2022 | Jinlin University, Sunshine Lake Pharma Co., Ltd. |
| NCT05395416 | Phase 2/Phase 3 (Phase 3) | Jun 21, 2021 | Sunshine Lake Pharma Co., Ltd., Tsinghua University |
| NCT04232514 | Phase 1 | Feb 20, 2020 | Jilin University, Sunshine Lake Pharma Co., Ltd. |
| NCT04202952 | Phase 1/Phase 2 (Phase 2) | Feb 10, 2020 | Jilin University, Sunshine Lake Pharma Co., Ltd. |
| NCT03903081 | Phase 1 | Mar 6, 2019 | Jilin University, Sunshine Lake Pharma Co., Ltd. |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sunshine Lake Pharma Co., Ltd. | For profit | 6 | 6 | 3 | 2019 |
| Jilin University | Academic/Hospital | 3 | 0 | 2 | 2019 |
| Jinlin University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Tsinghua University | Academic/Hospital | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1